{"id":"W4400151493","doi":"10.1016/j.annonc.2024.05.333","title":"419P Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Additional analyses from 4-year (y) follow-up (FU) of CheckMate 649","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Cancer; Gastroesophageal Junction; Internal medicine; Oncology; Chemotherapy; Esophageal adenocarcinoma; Esophageal cancer; Adenocarcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001780823,0.0008124297,0.001580313,0.0003669857,0.0003100247,0.001174389,0.0007342964,0.001254622,0.006470092],"category_scores_gemma":[0.002459133,0.0003698927,0.00608606,0.0003721519,0.000342923,0.001184182,0.0004634391,0.002245963,0.0005257955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007560854,"about_ca_system_score_gemma":0.000997255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004271634,"about_ca_topic_score_gemma":0.006998461,"domain_scores_codex":[0.9988134,0.0005149177,0.00004536361,0.0003061868,0.00006153921,0.0002585817],"domain_scores_gemma":[0.9987135,0.000696442,0.000177336,0.0001356224,0.00005006572,0.0002269077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8821746,0.002709547,0.06756285,0.000582261,0.0153307,0.0002000136,0.0001044585,0.001569488,0.003519225,0.0002160852,0.002687762,0.02334304],"study_design_scores_gemma":[0.1128164,0.2193878,0.5811154,0.0004213882,0.05474771,0.0005299106,0.0006528765,0.01409959,0.004802993,0.001575894,0.00968962,0.0001605114],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935976,0.002367371,0.0002203428,0.0002167139,0.0002095257,0.00008472647,0.002018858,0.00003109271,0.001253788],"genre_scores_gemma":[0.9943468,0.000611848,0.0002388846,0.0002928311,0.0001209563,0.0001115837,0.001687541,0.00001811586,0.002571507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006470092,"threshold_uncertainty_score":0.02164459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08238964688085516,"score_gpt":0.402549357995631,"score_spread":0.3201597111147758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}